-
Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta -hCG and PAPP-A at 10-14 weeks of gestation.
Tul N, Spencer K, Noble P, Chan C, Nicolaides K.
Prenat Diagn 1999;19:1035-42. -
Maternal age and gestation-specific risk for trisomy 21.
Snijders RJ, Sundberg K, Holzgreve W, Henry G, Nicolaides KH.
Ultrasound Obstet Gynecol 1999;13:167-70. -
Maternal serum S100 protein in normal and Down syndrome pregnancies.
Abraha HD, Noble PL, Nicolaides KH, Sherwood RA.
Prenat Diagn 1999;19:334-6. -
Collagen type VI gene expression in the skin of trisomy 21 fetuses.
von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH.
Obstet Gynecol 1998;91:319-23. -
UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation.
Snijders RJ, Noble P, Sebire N, Souka A, Nicolaides KH.
Lancet 1998;352:343-6. -
First trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K, Noble P, Snijders RJ, Nicolaides KH.
Prenat Diagn 1997;17:525-38. -
Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan.
Sherod C, Sebire NJ, Soares W, Snijders RJ, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;10:387-90. -
Maternal serum inhibin-A and free beta-hCG concentrations in trisomy 21 pregnancies at 10-14 weeks of gestation.
Noble PL, Wallace EM, Snijders RJ, Groome NP, Nicolaides KH.
BJOG 1997;104:367-71. -
Down's syndrome screening with nuchal translucency.
Nicolaides KH, Sebire NJ, Snijders RJ.
Lancet 1997;349:438. -
The maternal insulin-like growth factor (IGF) and IGF binding protein response to trisomic pregnancy during the first trimester: a possible diagnostic tool for trisomy 18 pregnancies.
Miell JP, Langford KS, Jones JS, Noble P, Westwood m, White A, Nicolaides KH.
J Clin Endocrinol Metab 1997;82:287-92. -
Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.
Sebire NJ, Snijders RJM, Hughes K, Sepulveda W, Nicolaides KH.
BJOG 1996;103:999-1003. -
Down's syndrome screeening in the UK.
Nicolaides KH, Sebire NJ, Snijders RJ, Johnson S, Reynolds TM.
Lancet 1996;347:906-7. -
Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency.
Hyett JH, Sebire NJ, Snijders RJM, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:101-3. -
Antenatal and postnatal treatment of pleural effusion and extra-lobar pulmonary sequestration.
Chan V, Greenough A, Nicolaides KN.
J Perinat Med 1996;24:335-8. -
Placental mRNA expression of alpha and beta human chorionic gonadotrophin in early trisomy 18 pregnancies.
Brizot ML, Jauniaux E, Mckie AT, Farzaneh F, Nicolaides KH.
Mol Hum Reprod 1996;2:463-5. -
Natural history of trisomy 21 Fetuses with fetal nuchal translucency.
Pandya PP, Snijders RJM, Johnson S, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;5:381-3. -
Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
Noble PL, Abraha HD, Snijders RJ, Sherwood R, Nicolaides KH.
Ultrasound Obstet Gynecol 1995;6:390-5. -
First trimester nuchal translucency and cardiac septal defects in fetuses with trisomy 21.
Hyett JA, Moscoso G, Nicolaides KH.
Am J Obstet Gynecol 1995;172:1411-3. -
Cardiac defects in 1st-trimester fetuses with trisomy 18.
Hyett JA, Moscoso G, Nicolaides KH.
Fetal Diagn Ther 1995;10:381-6. -
Increased nuchal translucency in Trisomy 21 fetuses: Relation to narrowing of the aortic isthmus.
Hyett JA, Moscoso G, Nicolaides KH.
Hum Reprod 1995;10:3049-3051.